This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Analog Devices,inc., Multerra Bio, Inc.. Active years: 2017-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Corte Madera, CA (US) (2023)
- Milpitas, CA (US) (2017 - 2024)
Company Filing History:
Years Active: 2017-2024
Title: Kee-Hyun Paik: Innovator in Molecular Detection Technologies
Introduction
Kee-Hyun Paik is a notable inventor based in Milpitas, CA (US). He has made significant contributions to the field of molecular detection, holding a total of 4 patents. His work focuses on developing advanced apparatuses and methods for analyzing charged analytes, which have important applications in clinical settings.
Latest Patents
Kee-Hyun Paik's latest patents include innovative technologies for detecting molecules and binding energy. One of his patents provides apparatuses and methods for analyzing the presence of charged analytes and the binding force between these analytes and a capture probe. This technology can be operated in a multiplexed format, allowing for various assays of clinical significance. Another patent similarly focuses on analyzing the presence of a target analyte, emphasizing the versatility and clinical relevance of his inventions.
Career Highlights
Throughout his career, Kee-Hyun Paik has worked with prominent companies such as Analog Devices, Inc. and Multerra Bio, Inc. His experience in these organizations has contributed to his expertise in the field of molecular detection technologies.
Collaborations
Kee-Hyun Paik has collaborated with talented individuals in his field, including Kaveh Milaninia and Kilian Dill. These collaborations have likely enhanced the innovation and development of his patented technologies.
Conclusion
Kee-Hyun Paik is a distinguished inventor whose work in molecular detection technologies has significant implications for clinical applications. His patents reflect a commitment to advancing the field and improving diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
